Details for 2017817175

Up to date per 03.04.2026

Actions

Title / Product Name

5-[[4-[2-[5-(1-HYDROXYETHYL)PYRIDIN-2-YL]ETHOXY]PHENYL]METHYL]-1,3-THIAZOLIDINE-2,4-DION ZUR BEHANDLUNG VON NONALKOHOLISCHEM STEATOHEPATITIS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017817175

EP Publication Number

3548026

E-Number

1355757

Language

PCT Number

IB17057587

Publication Date

09.10.2019 A

20.01.2021 B1

Registration Date

20.01.2021

AT Publication Date

15.02.2021

Application Date

01.12.2017

Registration Number

Priorities

01.12.2016

16382584

IPC

A61K 31/4439 20060101AFI20200720BHEP

Maximum Duration of Protection

01.12.2037

Owner

Minoryx Therapeutics S.L.Av. Ernest Lluch 32 08302 Mataró, BarcelonaES

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

PIZCUETA LALANZA, Maria Pilarc/o Minoryx Therapeutics S.L. Av. Ernest Lluch 32 08302 Mataró, BarcelonaES

MARTINELL PEDEMONTE, Marcc/o Minoryx Therapeutics S.L. Av. Ernest Lluch 32 08302 Mataró, BarcelonaES